These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18448972)

  • 41. Are multiple sclerosis patients risk-takers?
    Hawkes CH
    QJM; 2005 Dec; 98(12):895-911. PubMed ID: 16249207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An insight into molecular mechanisms of human T helper cell differentiation.
    Rautajoki KJ; Kylaniemi MK; Raghav SK; Rao K; Lahesmaa R
    Ann Med; 2008; 40(5):322-35. PubMed ID: 18484344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors in the development of multiple sclerosis.
    Munger KL; Ascherio A
    Expert Rev Clin Immunol; 2007 Sep; 3(5):739-48. PubMed ID: 20477024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidemiology of multiple sclerosis: insights to a causal cascade.
    Goodin DS
    Handb Clin Neurol; 2016; 138():173-206. PubMed ID: 27637959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allergy and multiple sclerosis: a population-based case-control study.
    Pedotti R; Farinotti M; Falcone C; Borgonovo L; Confalonieri P; Campanella A; Mantegazza R; Pastorello E; Filippini G
    Mult Scler; 2009 Aug; 15(8):899-906. PubMed ID: 19667018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the environment on multiple sclerosis.
    Løken-Amsrud KI; Lossius A; Torkildsen Ø; Holmøy T
    Tidsskr Nor Laegeforen; 2015 May; 135(9):856-60. PubMed ID: 25991624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
    Theoharides TC; Kempuraj D; Kourelis T; Manola A
    Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis.
    Greenstein JI
    Dev Neurobiol; 2007 Aug; 67(9):1248-65. PubMed ID: 17514718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunology of multiple sclerosis].
    Mussini JM
    Sem Hop; 1982 Dec; 58(45):2676-9. PubMed ID: 6297066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The involvement of mitochondria in the pathogenesis of multiple sclerosis.
    Kalman B; Laitinen K; Komoly S
    J Neuroimmunol; 2007 Aug; 188(1-2):1-12. PubMed ID: 17493689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.
    Mamutse G; Woolmore J; Pye E; Partridge J; Boggild M; Young C; Fryer A; Hoban PR; Rukin N; Alldersea J; Strange RC; Hawkins CP
    Mult Scler; 2008 Nov; 14(9):1280-3. PubMed ID: 18653739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.
    Fisher SG; Fisher RI
    Curr Opin Oncol; 2006 Sep; 18(5):417-24. PubMed ID: 16894287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of tobacco smoking in etiology of multiple sclerosis--review study].
    Wegrzyn D; Czarnywojtek A; Florek E
    Przegl Lek; 2006; 63(10):1144-5. PubMed ID: 17288241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.